agmo-1
C. elegans
Alkylglycerol monooxygenase
What the model saw
Gene: agmo-1 Organism: Caenorhabditis elegans Known functions: Alkylglycerol monooxygenase. glyceryl-ether monooxygenase activity.
View unredacted entry
Alkylglycerol monooxygenase. glyceryl-ether monooxygenase activity.
Solver output
Alkylglycerol monooxygenase (AGMO) catalyzes the oxidative cleavage of the ether bond in alkylglycerols (1-O-alkyl glycerols), converting them to fatty aldehydes and glycerol. Ether lipids, particularly plasmalogen-type ether phospholipids, are enriched in cell membranes and serve as endogenous antioxidants due to their vinyl-ether bond, which can scavenge reactive oxygen species. By degrading alkylglycerol ether lipids, agmo-1 modulates the balance of ether lipid species in membranes. In C. elegans, ether lipid metabolism has been linked to longevity pathways; loss of ether lipid synthesis (e.g., fard-1/AGPS) shortens lifespan, suggesting that maintaining ether lipid homeostasis is important. AGMO activity that degrades excess or aberrant ether lipids could help maintain lipid homeostasis and reduce lipotoxic or pro-inflammatory ether lipid intermediates, thereby supporting longevity. However, if AGMO over-degrades protective plasmalogens, it could be anti-longevity; the net effect is uncertain but leans slightly pro-longevity through lipid homeostasis maintenance.
GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.
Advisor judgment
The model correctly predicted pro_longevity for agmo-1, but the mechanistic reasoning is speculative and somewhat contradictory. The model acknowledges uncertainty about whether AGMO's degradation of ether lipids would be pro- or anti-longevity, and hedges significantly. The reasoning about plasmalogen degradation potentially being harmful contradicts the pro-longevity conclusion. The model appears to be reasoning by analogy from fard-1/AGPS (ether lipid synthesis) rather than from direct knowledge of agmo-1's role in longevity. The confidence of 0.55 reflects appropriate uncertainty, but the mechanistic pathway proposed is not clearly established. The correct answer was reached but the reasoning is not well-grounded in specific knowledge about agmo-1's longevity mechanism in C. elegans.
Raw API responses
solver
{
"reasoning": "Alkylglycerol monooxygenase (AGMO) catalyzes the oxidative cleavage of the ether bond in alkylglycerols (1-O-alkyl glycerols), converting them to fatty aldehydes and glycerol. Ether lipids, particularly plasmalogen-type ether phospholipids, are enriched in cell membranes and serve as endogenous antioxidants due to their vinyl-ether bond, which can scavenge reactive oxygen species. By degrading alkylglycerol ether lipids, agmo-1 modulates the balance of ether lipid species in membranes. In C. elegans, ether lipid metabolism has been linked to longevity pathways; loss of ether lipid synthesis (e.g., fard-1/AGPS) shortens lifespan, suggesting that maintaining ether lipid homeostasis is important. AGMO activity that degrades excess or aberrant ether lipids could help maintain lipid homeostasis and reduce lipotoxic or pro-inflammatory ether lipid intermediates, thereby supporting longevity. However, if AGMO over-degrades protective plasmalogens, it could be anti-longevity; the net effect is uncertain but leans slightly pro-longevity through lipid homeostasis maintenance.",
"confidence": 0.55,
"key_pathways": [
"ether lipid metabolism",
"lipid homeostasis",
"oxidative stress defense via plasmalogen regulation"
],
"mechanism_class": "other",
"longevity_influence": "pro_longevity"
}advisor
{
"notes": "The model correctly predicted pro_longevity for agmo-1, but the mechanistic reasoning is speculative and somewhat contradictory. The model acknowledges uncertainty about whether AGMO's degradation of ether lipids would be pro- or anti-longevity, and hedges significantly. The reasoning about plasmalogen degradation potentially being harmful contradicts the pro-longevity conclusion. The model appears to be reasoning by analogy from fard-1/AGPS (ether lipid synthesis) rather than from direct knowledge of agmo-1's role in longevity. The confidence of 0.55 reflects appropriate uncertainty, but the mechanistic pathway proposed is not clearly established. The correct answer was reached but the reasoning is not well-grounded in specific knowledge about agmo-1's longevity mechanism in C. elegans.",
"failure_mode": "right_answer_wrong_reasoning",
"answer_correct": true,
"mechanism_correct": false,
"reasoning_quality": 3,
"ground_truth_questionable": false
}